Literature DB >> 22648062

Secondary hypertrophic pachymeningitis in antiphospholipid syndrome.

Shin-ichi Tokushige1, Hideyuki Matsumoto, Tamiko Takemura, Yukifusa Igeta, Hideji Hashida.   

Abstract

This report describes a rare case of hypertrophic pachymeningitis secondary to antiphospholipid syndrome in a 37-year-old woman. The patient had a history of antiphospholipid syndrome and developed hypertrophic pachymeningitis subsequently. Pathological examination of the dura mater showed not only fibrous thickening, the typical finding of hypertrophic pachymeningitis, but also thrombosis in the dural microvessels and T cell infiltration without B cell or plasma cell infiltration, suggesting cell-mediated immunity. The dural thickening spontaneously improved and did not deteriorate during corticosteroid therapy. The histological findings and spontaneous remission observed in this case might be characteristic of secondary hypertrophic pachymeningitis with antiphospholipid syndrome. Further investigations are necessary to elucidate the pathophysiology of this novel type of hypertrophic pachymeningitis.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22648062     DOI: 10.1016/j.jneuroim.2012.05.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

Review 1.  A case report of atypical long segmental thoracic hypertrophic pachymeningitis with ossification of ligamentum flavum and literature review.

Authors:  Ruofu Tang; Fangcai Li; Qixin Chen
Journal:  Eur Spine J       Date:  2017-04-01       Impact factor: 3.134

2.  Sex-, stress-, and sympathetic post-ganglionic-dependent changes in identity and proportions of immune cells in the dura.

Authors:  Lisa A McIlvried; J Agustin Cruz; Lisa A Borghesi; Michael S Gold
Journal:  Cephalalgia       Date:  2016-07-11       Impact factor: 6.292

3.  Idiopathic hypertrophic pachymeningitis with anticardiolipin antibody: A case report.

Authors:  Chi-Shun Wu; Hung-Ping Wang; Sheng-Feng Sung
Journal:  Medicine (Baltimore)       Date:  2021-01-15       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.